Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Indietro
12 settembre 2017, 12:30
3562

Achillion Pharmaceuticals and J&J Were Slightly Down in Premarket Trading After the Discontinuation of Further Hepatitis C Treatment Investigation Was Announced

Achillion Pharmaceuticals and J&J Were Slightly Down in Premarket Trading After the Discontinuation of Further Hepatitis C Treatment Investigation Was Announced - immagine 1

Johnson & Johnson with Achillion Pharmaceuticals were down slightly at more than 20 percent in premarket trading after the announcement of Janssen Sciences Ireland about the discontinuation of further development of hepatitis C treatment investigation. The Janssen authorities comment on that it was a strategic decision because of the number of brand new therapy for hepatitis C, and the number increases rapidly.

"Going forward, our hepatitis R&D efforts will focus on chronic hepatitis B, where a high unmet medical need still exists," comment on  Lawrence Blatt, global therapeutic area head, infectious disease therapeutics, Janssen.

Autore: Liliya Ten

Condividi sui social media